Pharmaceutical Manufacturing Market Growth: Projected To Reach $846.74 Billion By 2029 With An Impressive 10.2% CAGR

June 19, 2025 10:11 AM BST | By EIN Presswire
 Pharmaceutical Manufacturing Market Growth: Projected To Reach $846.74 Billion By 2029 With An Impressive 10.2% CAGR
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, June 19, 2025 /EINPresswire.com/ -- The pharmaceutical manufacturing market size has grown rapidly in recent years. It substantially expanded from $519.78 billion in 2024 to an estimated $573.95 billion in 2025, reflecting a compound annual growth rate CAGR of 10.4%. Several factors fueled this growth, including an increasing global disease burden, upticks in healthcare spending, burgeoning demand for generic drugs, the expiration of patents for blockbuster drugs, and the expansion of pharmaceutical production capacity.

What Is The Projected Future Growth Of The Pharmaceutical Manufacturing Market Size?
Looking ahead, the pharmaceutical manufacturing market size is set to see rapid growth. It is projected to grow to a substantial $846.74 billion by 2029, boasting a CAGR of 10.2%. This growth arc is attributed to the momentum of personalized medicine, an expanding elderly population, the rising demand for biosimilars, and steady government support for local manufacturing. Major trends include continual advancements in manufacturing, the influx of artificial intelligence, adoption of smart manufacturing technologies, along with innovative strides in biologics production, and a sharpened focus on research and development efficiency.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24375&type=smp

What Are The Key Drivers Propelling The Growth Of The Pharmaceutical Manufacturing Market?
A significant driver for this anticipated pharmaceutical manufacturing market growth is the increasing prevalence of chronic diseases; long-lasting health conditions that typically progress slowly and require ongoing medical attention. As life expectancy increases and lifestyles become increasingly sedentary, the prevalence of chronic diseases rises. This in turn creates a growing demand for long-term healthcare solutions and preventive wellness measures. Pharmaceutical manufacturing serves chronic diseases by providing a steady supply of essential medications, fostering innovation in drug development, and meeting the growing demand for effective long-term treatment solutions.

What Key Player Strategies Are Driving The Pharmaceutical Manufacturing Market?
The pharmaceutical manufacturing market segment boasts key industry players such as Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, and others.

Report Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-manufacturing-global-market-report

What Are The Emerging Trends In The Pharmaceutical Manufacturing Market?
One significant emerging trend is the focus by these major entities on developing fully automated RLT manufacturing facilities. These state-of-the-art production sites use advanced automation technologies to streamline and optimize the production of radioligand therapies, ensuring consistency, efficiency, and scalable manufacturing.

How Is The Pharmaceutical Manufacturing Market Segmented?
The pharmaceutical manufacturing market is segmented by molecule type into Biologics and Biosimilars, and Conventional Drugs. In terms of formulation, it is categorized into Tablets, Capsules, Injectable, Sprays, suspensions, Powders, and other formulations. The route of administration is classified as Oral, Topical, Parenteral, Inhalations, and other routes. By therapy area, it covers Cardiovascular Diseases CVDs, Pain, Diabetes, Cancer, Respiratory Diseases, and other diseases. It is also segmented by sales channel into retail and non-retail.

What Are The Regional Insights In The Pharmaceutical Manufacturing Market?
In terms of regional insights, North America was the dominant region in the pharmaceutical manufacturing market as of 2024, while Asia-Pacific is touted to be the fastest-growing region in the forecast period. The report covers all regions, including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:
Companion Animal Pharmaceuticals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/companion-animal-pharmaceuticals-global-market-report

Ethical Pharmaceuticals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ethical-pharmaceuticals-global-market-report

Biopharmaceuticals Contract Manufacturing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biopharmaceuticals-contract-manufacturing-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next